<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e>) is a systemic disorder of the connective tissues caused by insufficient fibrillin-1 microfibril formation and can cause cardiac complications, <z:hpo ids='HP_0002097'>emphysema</z:hpo>, ocular <z:hpo ids='HP_0001083'>lens dislocation</z:hpo>, and severe <z:e sem="disease" ids="C0031090" disease_type="Disease or Syndrome" abbrv="">periodontal disease</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>ADAMTSL6β (A disintegrin-like metalloprotease domain with thrombospondin type I motifs-like 6β) is a microfibril-associated extracellular matrix protein expressed in various connective tissues that has been implicated in fibrillin-1 microfibril assembly </plain></SENT>
<SENT sid="2" pm="."><plain>We here report that ADAMTSL6β plays an essential role in the development and regeneration of connective tissues </plain></SENT>
<SENT sid="3" pm="."><plain>ADAMTSL6β expression rescues microfibril disorder after periodontal ligament injury in an <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> mouse model through the promotion of fibrillin-1 microfibril assembly </plain></SENT>
<SENT sid="4" pm="."><plain>In addition, improved fibrillin-1 assembly in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> mice following the administration of ADAMTSL6β attenuates the overactivation of TGF-β signals associated with the increased release of active TGF-β from disrupted fibrillin-1 microfibrils within periodontal ligaments </plain></SENT>
<SENT sid="5" pm="."><plain>Our current data thus demonstrate the essential contribution of ADAMTSL6β to fibrillin-1 microfibril formation </plain></SENT>
<SENT sid="6" pm="."><plain>These findings also suggest a new therapeutic strategy for the treatment of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> through ADAMTSL6β-mediated fibrillin-1 microfibril assembly </plain></SENT>
</text></document>